Evidence map›Paper›PMID 26656717›Full record

ArticleJournal of virology2015

The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.

Adriana Forero, Jennifer Tisoncik-Go, Tokiko Watanabe, Gongxun Zhong, Masato Hatta, Nicolas Tchitchek, Christian Selinger, Jean Chang, Kristi Barker, Juliet Morrison and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptation.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Review
  16. Erucic acid fromJournal of pharmaceutical analysis · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Adriana ForeroDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Jennifer Tisoncik-GoDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Tokiko WatanabeDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Gongxun ZhongDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Masato HattaDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Nicolas TchitchekDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Christian SelingerDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Jean ChangDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Kristi BarkerDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Juliet MorrisonDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Jason D BerndtHoward Hughes Medical Institute, Institute for Stem Cell and Regenerative Medicine, and Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
Randall T MoonHoward Hughes Medical Institute, Institute for Stem Cell and Regenerative Medicine, and Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington, USA.
Laurence JossetLaboratory of Virology, National Influenza Centre (South of France), Hospices Civils de Lyon, Bron, France, and Laboratorie Virpath EA4610, Université Claude Bernard Lyon 1, Lyon, France.
Yoshihiro KawaokaDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Michael G KatzeDepartment of Microbiology, University of Washington, Seattle, Washington, USA Washington National Primate Research Center, University of Washington, Seattle, Washington, USA honey@uw.edu.
University of Washington · USUniversity of Wisconsin–Madison · USHoward Hughes Medical Institute · USVirologie et Pathologies Humaines · FR

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2014 to 2018
$32.6M
Molecular Mechanisms for the High Pathogenicity of 1918 Influenza VirusR01AI080598 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAWAOKA, YOSHIHIRO · 2009 to 2013
$3.2M
Intramural NIH HHSNIAID NIH HHS R01 AI080598NIAID NIH HHS R01AI080598NIAID NIH HHS U19 AI109761NIAID NIH HHS U19AI109761NIH HHS P51 OD010425NIH HHS P51OD010425
6 · The paper itself

Abstract

unlabelledThe 1918-1919 influenza pandemic remains the single greatest infectious disease outbreak in the past century. Mouse and nonhuman primate infection models have shown that the 1918 virus induces overly aggressive innate and proinflammatory responses. To understand the response to viral infection and the role of individual 1918 genes on the host response to the 1918 virus, we examined reassortant avian viruses nearly identical to the pandemic 1918 virus (1918-like avian virus) carrying either the 1918 hemagglutinin (HA) or PB2 gene. In mice, both genes enhanced 1918-like avian virus replication, but only the mammalian host adaptation of the 1918-like avian virus through reassortment of the 1918 PB2 led to increased lethality. Through the combination of viral genetics and host transcriptional profiling, we provide a multidimensional view of the molecular mechanisms by which the 1918 PB2 gene drives viral pathogenicity. We demonstrate that 1918 PB2 enhances immune and inflammatory responses concomitant with increased cellular infiltration in the lung. We also show for the first time, that 1918 PB2 expression results in the repression of both canonical and noncanonical Wnt signaling pathways, which are crucial for inflammation-mediated lung regeneration and repair. Finally, we utilize regulatory enrichment and network analysis to define the molecular regulators of inflammation, epithelial regeneration, and lung immunopathology that are dysregulated during influenza virus infection. Taken together, our data suggest that while both HA and PB2 are important for viral replication, only 1918 PB2 exacerbates lung damage in mice infected with a reassortant 1918-like avian virus. IMPORTANCE: As viral pathogenesis is determined in part by the host response, understanding the key host molecular driver(s) of virus-mediated disease, in relation to individual viral genes, is a promising approach to host-oriented drug efforts in preventing disease. Previous studies have demonstrated the importance of host adaptive genes, HA and PB2, in mediating disease although the mechanisms by which they do so are still poorly understood. Here, we combine viral genetics and host transcriptional profiling to show that although both 1918 HA and 1918 PB2 are important mediators of efficient viral replication, only 1918 PB2 impacts the pathogenicity of an avian influenza virus sharing high homology to the 1918 pandemic influenza virus. We demonstrate that 1918 PB2 enhances deleterious inflammatory responses and the inhibition of regeneration and repair functions coordinated by Wnt signaling in the lungs of infected mice, thereby promoting virus-associated disease.

Indexed as

AnimalsCell LineDisease Models, AnimalFemaleGene Expression ProfilingHemagglutinin Glycoproteins, Influenza VirusHumansInflammationInfluenza A Virus, H1N1 SubtypeLungMice, Inbred BALB COrthomyxoviridae InfectionsReassortant VirusesRNA-Dependent RNA PolymeraseViral ProteinsVirulenceHemagglutinin Glycoproteins, Influenza Virushemagglutinin, human influenza A virusPB2 protein, Influenzavirus ARNA-Dependent RNA PolymeraseViral ProteinsVirulence Factors

Identifiers

PMID26656717
PMCPMC4810726
OpenAlexW2284189835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.